Tivic Reports Full Year 2025 Results

Completes Strategic Transformation into an Immunotherapy Company and Continues to Advance Entolimod Platform Toward Potential Funding PartnershipsConference Call to be Held Today at 1:30 PM PT / 4:30 PM ET SAN ANTONIO, TX / ACCESS Newswire / March …